Peter Lewandrowski;Jens Fritsche;Steffen Walter;Harpreet Singh;Toni Weinschenk
发明人:
Toni Weinschenk,Jens Fritsche,Steffen Walter,Peter Lewandrowski,Harpreet Singh
申请号：
US13635896
公开号：
US10064913B2
申请日:
2011.03.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
